logomark
Research

Research

BDR researchers coming from diverse research fields are working together to achieve higher goals.

Seminars & Symposia

Seminars & Symposia

BDR hosts annual symposium and regular seminars inviting international scientists in life science.

Careers & Study

Careers & Study

BDR embraces people from diverse backgrounds, and strives to create an open and supportive setting for research.

Outreach

Outreach

BDR communicates the appeal and significance of our research to society through the use of various media and activities.

News

News

From research, events, people and everything in between, find out what’s going on at RIKEN BDR.

About Us

About Us

Exploring the scientific foundations of life through interdisciplinary approaches to address society’s problems.

Getting Insights into Cell Biology by Network Reconstruction and Modelling
Jun. 13, 2019 14:00 - 15:30

Category

Seminar

Place

Osaka

Venue

Osaka LargeConferenceRoom A3F

Speaker

Boris N. Kholodenko

Affiliation

Systems Biology Ireland, University College Dublin, Belfield, Dublin, Ireland Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA

Summary

Omics technologies have generated large inventories of genes, transcripts, proteins, and metabolites. The challenge is to find out how they work together to regulate cellular responses to external and internal cues. Computational models provide insight into the intricate relationships between stimuli and cellular responses. I first overview a suite of physics-based methods, known as Modular Response Analysis, which infer both direct causative connections and their strengths in cellular signaling and gene networks from perturbation data (https://www.ncbi.nlm.nih.gov/pubmed/12242336). Further, I show that drug resistance resulting from dimerization of kinases (such as, BRAF/CRAF, JAK2, etc) can be explained by allosteric inhibitor effects and the emergence of different drug affinities between free kinase monomers versus dimers (https://www.ncbi.nlm.nih.gov/pubmed/26344764). Finally, I overview an exciting and counterintuitive discovery made using a new type of mathematical modelling, which combines aspects of protein structure, posttranslational modifications, thermodynamics, and dynamic reaction mechanisms (https://www.ncbi.nlm.nih.gov/pubmed/30007540). We used model predictions to block oncogenic RAS signalling in metastatic melanoma cells. RAS is mutated in 30% of all human cancers, and RAS mutated cancers are clinically considered to be undruggable and resistant to current treatments. Our approach identified non-intuitive drug combinations that synergise to block critical RAS effector pathways.

Host

Mariko Okada

PAGE
TOP